GDEV (GDEV) director receives 7,906 fully vested stock options exercisable to 2031

Rhea-AI Filing Summary

GDEV Inc. director Marie Juliette France Holive received a grant of stock options covering 7,906 Ordinary Shares. The options were awarded at an exercise price of $0.00 per share, are fully vested and exercisable, and expire on November 16, 2031. Following the grant, she holds 7,906 derivative securities directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Holive Marie Juliette France

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	7,906	$0.00	--

Holdings After Transaction: Stock Option — 7,906 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 7,906 options Exercise price: $0.00 per share Underlying shares: 7,906 Ordinary Shares +2 more

5 metrics

Options granted 7,906 options Stock option award to director on June 30, 2026

Exercise price $0.00 per share Stock option exercise price for 7,906 underlying shares

Underlying shares 7,906 Ordinary Shares Shares subject to the stock option grant

Expiration date November 16, 2031 Option term end date

Post-grant derivative holdings 7,906 derivative securities Total stock options held following the transaction

Key Terms

Stock Option, Ordinary Shares, derivative securities, Grant, award, or other acquisition, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

derivative securities financial

"total_shares_following_transaction: "7906.0000" (derivative securities)"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

fully vested and exercisable financial

"footnote: "The stock option is fully vested and exercisable.""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:17 PM Accepted by SEC EDGAR 07/01/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holive Marie Juliette France

(Last) (First) (Middle)

C/O GDEV INC.

55, GRIVA DIGENI

(Street)

LIMASSOL 3101

(City) (State) (Zip)

CYPRUS

(Country)

2. Issuer Name and Ticker or Trading Symbol
GDEV Inc. [ GDEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0	06/30/2026		A		7,906		(1)	11/16/2031	Ordinary Shares	7,906	$0	7,906	D

Explanation of Responses:

1. The stock option is fully vested and exercisable.

	/s/ Olga Koveza, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did GDEV (GDEV) disclose in this Form 4 filing?

GDEV reported that director Marie Juliette France Holive received a grant of stock options for 7,906 Ordinary Shares. These options are fully vested, exercisable at $0.00 per share, and expire on November 16, 2031, reflecting equity-based director compensation.

How many GDEV (GDEV) stock options were granted to the director?

The director was granted stock options covering 7,906 shares of GDEV Ordinary Shares. This entire amount became fully vested immediately, giving her the right to acquire up to 7,906 underlying shares under the terms of the option award.

What is the exercise price and term of the GDEV (GDEV) stock options?

The stock options have an exercise price of $0.00 per share and expire on November 16, 2031. This means the director can acquire 7,906 Ordinary Shares without paying an exercise price any time before that expiration date.

Are the newly granted GDEV (GDEV) stock options vested?

Yes. A footnote states the GDEV stock option grant is fully vested and exercisable. The director therefore has immediate ability to exercise the option for 7,906 Ordinary Shares, subject to the overall terms and expiration date of November 16, 2031.

How many derivative securities does the GDEV (GDEV) director hold after this grant?

After the transaction, the director’s reported holdings include 7,906 derivative securities in the form of stock options. These options relate to 7,906 underlying Ordinary Shares, providing direct equity-linked exposure through this compensation award.